Patients with a complex, chronic disorder don’t have a single cause for their disease. Each patient has a unique combination of genetic and environmental risk factors. Currently, many complex diseases are detected too late in their progression based on symptoms that can be misleading.

Ariel goes beyond genetics to provide valuable information to clarify risk and guide a personalized approach to the early detection of complex diseases such as pancreatitis and pancreatic cancer.

Our ADVANCE® analysis combines genetics, environmental and patient-specific data with clinical guidance supported by the most current scientific evidence to provide a comprehensive and actionable risk assessment to inform screening for early detection, risk-reducing strategies, and treatment.

Ariel’s new SNaP-Shot approach analyzes carefully annotated genetic variants with known effects and integrates this data with the patient’s medical history and current symptoms to provide a comprehensive overview of the factors that may be contributing to current conditions. Our genetic reporting provides genetic, biological markers along with evidence-based guidelines that are individualized to each patient.